Provided by Tiger Trade Technology Pte. Ltd.

EVEREST MED

29.600
+0.8002.78%
Volume:4.78M
Turnover:140.36M
Market Cap:10.48B
PE:-33.26
High:30.580
Open:29.480
Low:28.700
Close:28.800
52wk High:55.900
52wk Low:22.700
Shares:354.00M
HK Float Shares:354.00M
Volume Ratio:2.48
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.890
ROE:-1.18%
ROA:-1.06%
PB:1.71
PE(LYR):-33.26
PS:3.71

Loading ...

Everest Medicines (SEHK:1952) Forms ESG Committee, Is The Stock 32% Undervalued?

Simply Wall St.
·
Yesterday

Everest Medicines Appoints Ex-Moderna Executive Lakshmi Srinivasan as Head of Translational Medicine

Reuters
·
Yesterday

Everest Medicines Opens Up Over 5%, Appoints Two Moderna Oncology Vaccine Scientists to Accelerate Global mRNA Clinical Development

Deep News
·
Yesterday

Movement Alert|EVEREST MED Rises 5.21% in Regular Trading, Two Former Moderna mRNA Talents Join

Market Focus
·
Yesterday

Everest Medicines Welcomes Two Top mRNA Experts to Accelerate Global Innovation Strategy

Stock News
·
Yesterday

Movement Alert|EVEREST MED Falls 6.17% in Regular Trading, Biotech Sector Retreat Weighs

Market Focus
·
Oct 07

Movement Alert | EVEREST MED Rises 5.07% in Regular Trading, Broker Upgrade and Strong Nefecon Sales Drive Gains

Market Focus
·
Oct 06

Movement Alert|EVEREST MED Falls 5.04% in Regular Trading, Biotech Sector Pulls Back After Prior Session mRNA Rally

Market Focus
·
Oct 02

Movement Alert|EVEREST MED Falls 6.7% at Open, Pulling Back After Previous Sessions Strong Rally on Innovative Drug and mRNA Sector Gains

Market Focus
·
Oct 02

Everest Medicines Stock In Focus After China Approval For CARDAMYST

Simply Wall St.
·
Oct 01

Hong Kong Stock Movers: mRNA Concept Stocks Lead Gains, CanSinoBIO (06185) Surges Over 17% as Moderna's mRNA Neoantigen Therapy Set to Debut at ESMO Congress

Stock News
·
Sep 30

Movement Alert|EVEREST MED Rises 5.72% in Regular Trading, Medical Industry Policy and mRNA Pipeline Progress Boost Sentiment

Market Focus
·
Sep 30

Everest Medicines Sets Up ESG Committee, Names Four Directors Including Chairman Yifang Wu

Bulletin Express
·
Sep 28

Everest Medicines Establishes ESG Committee to Strengthen Sustainability Governance

Bulletin Express
·
Sep 28

Everest Medicines Forms ESG Committee

Stock News
·
Sep 28

Movement Alert|EVEREST MED Declines 5.04% in Regular Trading, Trading at HK$27.54

Market Focus
·
Sep 24

HK Movers | Biotech Names Firmed: CANSINOBIO up Nearly 10%, JW THERAP-B up More Than 7%

Tiger Newspress
·
Sep 23

Movement Alert|EVEREST MED Rises 5.23% in Regular Trading, Weshiping Domestic Production Registration Accepted with Priority Review

Market Focus
·
Sep 23

HK Movers | Innovative Drug Stocks Rally Broadly; LEPU BIO, INNOCARE, AKESO Jump Over 7%

Tiger Newspress
·
Sep 21

Movement Alert|EVEREST MED Rises 5.8% in Regular Trading, Velsipity Domestic Production Application Accepted with Priority Review

Market Focus
·
Sep 21